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Abstract 
Introduction: Urinary tract infection is an inflammation of the urinary tract that occurs when micro organisms, 
usually bacteria from digestive tract or vagina cling to the opening of the urethra and begin to multiply. An estimated 
150 million urinary tract infections occur annually worldwide. Indiscriminate use of antibiotics has resulted in the 
emergence of drug resistant pathogens now. 
Objective: To determine the prevalence and drug susceptibility patterns of bacterial pathogens involved in urinary 
tract infections within the last three years, January 1st 2008 to December 30th 2010 in Tikur Anbesa Specialized 
Teaching Hospital of Addis Ababa, Ethiopia.   
Method: An institution-based retrospective cross sectional population survey was conducted in the clinical laboratory 
for diagnosis of patients visiting Tikur Anbessa Specialized Teaching Hospital. Collected secondary data were entered 
and analyzed using SPSS version 17 computer software package. Percentages and ratios were calculated in tables. P-
value was used to see statistical significance (p<0.05). 
Results: Out of 3254 recorded patient’s data 3182 results were taken and analyzed. The overall prevalence of urinary 
tract infection was 23.32 % and the highest prevalence was obtained among age groups 21-30 years (27.16%).  The 
bacterial pathogens isolated were predominantly, Escherchia coli: 361 (44.62%), followed by Klebsella Spp: 136 
(16.81%), Coaggulase negative Staphylococci Spp: 49 (6.06%) and Entrococci Spp: 41 (5.06%). The invitro drug 
sensitivity testing showed that both gram negative and gram-positive organisms were extremely resistant to 
Ampiciline: (83.93%), Amoxicillin: (78.87%) and Tetracycline: (77.75%). 
Conclusion: the prevalence of urinary tract infection was high, and the drug resistance rate was extremely high. For 
this reason, it is necessary to minimize the rate of urinary tract infections, and to constantly monitor susceptibility 
patterns of specific pathogens to commonly used antimicrobial agents before antibiotic therapy initiation.  [Ethiop. J. 
Health Dev.  2013;27(2):111-117] 
 
Introduction 
Urinary tract infection (UTI) is the colonization, invasion 
and propagation of infectious agents in the unitary tract 
including the urethra, bladder, renal pelvis or renal 
parenchyma (1). Urinary tract infections are the second 
most common type of infection of the body, accounting 
for about 8.1 million visits to health care providers each 
year (2). 
 
An infection occurs when organisms, usually bacteria 
from the digestive tract or vagina cling to the opening of 
the urethra and begins to multiply (3). Additionally, 
exogenous hospital acquired UTIs may occur following 
instrumentation of the urinary tract, mainly urinary 
catheterization (4).  Generally, Escherichia coli and 
Staphylococcus saprophyticus cause approximately 80% 
and 15% of acute UTIs, respectively in patients without 
catheters, stone or other urologic abnormalities (3-4).  On 
the other hand, organisms like Klebsella spp, 
Enterobacteria spp, Proteus spp, Entrococcus, spp and 
Pseudomonas aurogenosa assume greater importance in 
recurrent infections associated with urologic 
manipulations as in catheter associated nosocomial 
infection (5, 6). 
 
In symptomatic straightforward cases, a combination of 
symptoms (i.e., dysuria, frequency, and absence of 
discharge) raised the probability of UTI to more than 90 
percent. In this case, diagnosis may be made and 
treatment given based on symptoms alone without further 
laboratory investigations. However, UTIs have to be 
distinguished from other diseases that have similar 
clinical presentation. Some urinary tract infections are 
asymptomatic or present with atypical signs. For this 
reason, clinical diagnosis needs to be confirmed by 
laboratory tests (7). Clean catch midstream urine 
collected and refrigerated in a sterile container can be 
used within 2 hr for urinalysis test, culture and drug 
sensitivity test (8). 
The diagnosis of urinary tract infection is based on a 
quantitative urine culture yielding greater than 100,000 
 
1Haramay University, College of Medical Sciences, Department of Laboratory Sciences, P.O. Box 1154, Harar, Tel: 
25l0911815703, Fax 251-256668081, E-mail getachew.kabew@yahoo.com; 
2Addis Ababa University, College of Medical Sciences, Department of Microbiology, Immunology and Parasitology; 
e-mail: tabebezeleke@gmail.com, or adane_mihret@yahoo.com. 
112     Ethiop. J. Health Dev. 
 
colony forming units per milliliter of urine, which is 
termed significant bacteruria.  This value was chosen 
because of its high specificity for the diagnosis of true 
UTI even in asymptomatic persons (8,9). 
 
The choice of drug and length of treatment depend on the 
patient’s history and the urine tests that identify the 
offending bacteria (10). Routine uncomplicated UTIs can 
be treated with Nitrofurantoin, Trimethoprim-
sulfamethoxazole, Fluoroquinolones (Ofloxacin, 
Ciprofloxacin, and Levofloxacin), Cephalosporin, 
Cephalexin and intravenous antibiotics for 14 days or 
long term low dose antibiotic treatment may be necessary 
in patients with frequent re-infection (11,12). 
 
The sensitivity test is especially useful in helping the 
physician select drugs to treat UTIs (13). This is 
particularly true because of the increased incidence of 
antimicrobial resistance (AMR). Microbial drug 
resistance is how a major problem in treating infectious 
diseases worldwide (14). It is aggravated by the increased 
use of muddled empirical therapeutic treatments, mainly 
in economically disadvantaged countries like Ethiopia, 
that do not have quality microbiological laboratory 
facilities to isolate pathogens and determine their drug 
susceptibility pattern (16-17).  Consequences of AMR, 
especially multidrug resistance include increased 
mortality, morbidity, and health care costs (17). For this 
reason, improvement of microbiological laboratory 
facility and laboratory professional skill in line with 
improving all the health care services should be enhanced 
across the country. 
 
The general purpose of this study was to determine the 
prevalence and drug susceptibility patterns of bacterial 
pathogens involved in urinary tract infections in Tikur 
Anbesa Specialized Teaching Hospital, Addis Ababa. 
 
Methods 
Study Area  
The study was done in the capital city of Ethiopia, Addis 
Ababa. According to the 2007 census preliminary report 
of the Central Statistical Authority, the total population 
of Addis Ababa was estimated to be 3.2 millions. Tikur 
Anbassa Hospital founded in 1964, is the largest and 
most specialized referral hospital in the country.  This 
hospital provides health services for approximately 
370,000- 400,000 patients per a year. 
 
Source Population  
All patients of this study visited Tikur Anbassa 
Specialized teaching Hospital from January 1st 2008 to 
December 30th 2010. 
 
Study Population  
All symptomatic patients sent to Tikur Anbassa 
Specialized teaching Hospital microbiology laboratory 
for diagnosis of urinary tract infections were included in 
the study. 
 
Study Design and Period  
An institution-based, descriptive, retrospective and cross-
sectional population survey was conducted in Tikur 
Anbassa Specialized teaching Hospital within the three 
years, January 1st 2008 to December 30th 2010.  
 
Eligibility Inclusion and Exclusion Criteria   
Inclusion criteria: Data recorded have at least sex and age 
were included in the study. 
 
Exclusion criteria: Data recorded with incomplete sex 
and age information were excluded from the study. 
 
Variables 
 Dependent variable  
Prevalence of urinary tract infection and drug 
susceptibility patterns of uropathogenes. 
 
 Independent variables  




Urine sampling and processing  
Midstream urine samples were collected from a total 
3254 suspected UTI patients. Growth of 105 colony 
forming units (CFU)/mL was considered a positive urine 
culture (18). Uropathogens were isolated and identified 
according to NCCLS standard morphological, cultural 
and biochemical methods (19). 
 
Determining of antimicrobial susceptibility:  
Kirby-Bauer disc diffusion assay on Muller Hinton agar 
was carried out to determine the antimicrobial 
susceptibility profiles (20). The panel antimicrobials 
included amoxicillin: 30 mg, gentamicin: 10 mg, 
cefotaxime: 30 mg, nalidixic: acid 30 mg, ciprofloxacin: 
5 mg, ofloxacin: 5 mg, norfloxacin: 10 mg, 
erythromycin: 15 mg, cloxacillin: 5 mg, vancomycin: 30 
mg, nitrofurantoin: 300 mg and tetracycline: 30 mg. 
  
Data Quality Control  
Secondary data were gathered from Tikur Anbassa 
specialized teaching Hospital is microbiology laboratory 
records for processing, analyzing and determining 
prevalence and drug susceptibility patterns of 
uropathogenes. The collected data was checked for its 
completeness, accuracy, clarity and consistency before 
being entered into data entry forms. When any ambiguity 
or incompleteness was encountered, it were recorded and 
corrected immediately before proceeding to the next. 
 
Data Analysis: The collected data were sorted in the 
prepared format. The laboratory result of the study was 
categorized based on age groups and sex. Isolates 
prevalence rate calculations, frequency distributions, 
susceptibility patterns and other descriptive statistics 
were computed and reviewed. Percentages and ratios 
were calculated in tables. SPSS version 17 computer 
Ethiop. J. Health Dev. 2013;27(2) 
Antimicrobial susceptibility test, Tikure Anbesa specialized teaching hospital, urinary tract infection     113 
 
software package was used for data analysis. P-value was 
used to see statistical significance (p<0.05). 
 
Ethical Considerations 
Ethically, the study was cleared and an official letter was 
written from Addis Ababa University (AAU) Faculty of 
Medicine, Department of Microbiology, Immunology 
and Parasitology to Tikur Anbesa Specialized Teaching 
Hospital. We agreed and signed the appropriate form. 
Given that it is a retrospective study, informed consents 
were not asked. The study didn't require patient’s name 
or any personal identification details thereby assuring 




Out of being the 3254 recorded patients’ data, 3182 
laboratory results were taken and analyzed. Because of 
their incomplete information about 72(2.2%) of subjects’ 
data were excluded from the study. Females the subjects 
were 1827 (57.42%) and males 1355 (42.58%). The 
mean age of the study was 34.09 with 16.02 years SD. 
 
The overall prevalence of urinary tract infection was 
23.32 % and the highest prevalence rate was obtained 
from 21-30 years age group (27.16%) (Table1). UTI was 
relatively higher in females 428 (23.43%) than males 314 
(23.17%); however this was not found to be statistically 
significant (p=0.89). 
 
Table 1:  Age specific prevalence’s of urinary tract 
infections in Tikur Anbessa Specialized Teaching 
Hospital, Addis Ababa, Ethiopia, and January 1st 2008 













< 1 176 41 23.29 % 
1-10 937 208 22.19% 
11-20 535 99 18.50 % 
21-30 567 154 27.16 % 
31-40 310 79 25.48 % 
41-50 253 61 24.11% 
51-60 237 58 24.47 % 
≥61 167 42 25.15 % 
Total 3182 742 23.32 %  
(an overall  
prevalence) 
 
The bacterial pathogens isolated were predominantly, 
Escherichia coli: 361 (44.62%), followed by Klebsella 
Spp: 136 (16.81%), coaggulase negative Staphylococcus 
Spp: 49 (6.06%) and Entrococcus Spp: 41 (5.07%). Over 
all, UTI was mainly caused by gram-negative bacteria 
690 (85.3%) than gram positive 119 (14.7%) (Table2). 
Multiple infections were observed in 67 (9.03 %) of UTI 
patients. 
Table 2:  Distribution of isolated organisms in Tikur Anbessa Specialized Teaching Hospital, Addis Ababa, 
Ethiopia, January 1st 2008 to December 30th 2010 
Pathogenic bacteria Isolated   No of isolates Total Frequency Percentage 
 OPD IPD 
Escherichia coli  137 224 361 44.63% 
Klebsella species  46 90 136 16.81% 
Coaggulase negative staph. spp.  23 26 49 6.06% 
Enterocci species   12 29 41 5.07% 
Acinetobacter species  16 23 39 4.82.% 
Entrobacter species 13 16 29 3.58% 
Citrobacter species 5 22 27 3.34% 
Pseudomonas aerogenosa 10 17 27 3.34% 
Providencia rettigeri  8 18 26 3.21% 
Staphylococcus  aureus 6 19 25 3.09% 
Morgenella morganii 6 9 15 1.85% 
Proteous vulgaris 3 7 10 1.24% 
Proteous mirabilis 1 8 9 1.11% 
Salmonella species  0 8 8 0.99% 
Streptococcus species 0 4 4 0.49% 
Serratia species 0 3 3 0.37% 
Total 286 523 809 100% 
Note: OPD=Outpatient department, IPD=Inpatient department 
 
 
Organisms were isolated more frequently from inpatients 
(IP) than outpatients (OP) and there was a statistical 
significance (P=0.0005). Calculated inpatient to 
outpatient odds ratio of urinary tract infections was [OR= 





Table 3: Calculated odds ratio of UTI in inpatients to outpatients in Tikur Anbessa  
Hospital, Addis Ababa, Ethiopia, January 1st 2008 to December 30th 2010 
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Type of patient Positive Negative Odds ratio 
Inpatient 474 1384 1.35 [OR= 1.35; 95% CI:1.13-1.61; 
p=0.0005] 
Outpatient 268 1056  
Total 742 2440  
 
Antibiotic Susceptibility Patterns 
In this study, based on the recorded data some discs such 
as vancomycin, cloxacilin, streptomycin, erythromycin 
and mithicilin for antibiotic susceptibility pattern test 
were used inconsistently because of blinking supply, and 
inappropriately against to organisms which have intrinsic 
resistance to that particular drug. 
 
The gram-negative isolates were mainly sensitive to 
Ciprofloxacin (62.68%), Norfloxacin (61.08%) and 
Nitrofurantoin (50.49%) while they were resistant to 
most antibiotics such as Amoxicillin (85.12%), Ampcilin 
(81.22%) and Tetracycline (80.02%). It was observed 
that gram-positive isolates were relatively sensitive to 
Nitrofurantoin (66.30%), Chloramphinicol (60.55%) and 
Gentamycin (58.53%) while they were commonly 
resistant to Ampicilin (81.7%), Tetracycline (78.03%) 
and Deoxicyclin (65.87%). The in vitro sensitivity testing 
showed that both gram negative and gram-positive 
organisms were extremely resistant to Ampciline 
(83.93%), Amoxicillin (78.7%) and Tetracycline 
(77.75%). 
 
Proteus vulgaris and Proteus mirabilis showed that a 100 
% sensitivity to Augmentin. Complete resistance was 
observed in Entrococcus Spp and Pseudomonas 
aeurogenosa to penicillin G, Morgenella morgenii to 
Ampcilin, Tetracycline and Amoxicillin, and Salmonella 
Spp to Cefotaxim.  The highest level of resistance was 
observed against Ampcilin. Results indicated that 
Nitrofurantoin was the most potent of all the antibiotics. 
Antibiotic susceptibility data showed that 771 (95.3%) 
isolates were resistant to at least one antibiotic and most 
of the isolates, 747 (92.34%) were resistant against two 
or more antibiotics (Table 4). 
 
Table 4: Multi-drug resistant patterns of isolates of UTI in Tikur Anbessa Specialized Teaching  
Hospital, Addis Ababa, Ethiopia, January 1st 2008 to December 30th 2010 
Type of Isolate  R0 R1 R2 R3 R4 R5 R6 ≥R7 
Escherichia coli  30 10 10 19 19 35 60 178 
Klebsella species  1 2 5 8 7 10 14 89 
Coaggulase negative staph. spp.  2 1 0 7 5 4 5 25 
Enterocci species   0 0 1 4 4 2 4 26 
Acinetobacter species  0 1 0 2 2 0 1 33 
Entrobacter species 1 1 0 2 0 0 6 19 
Citrobacter species 0 3 0 1 0 0 5 18 
Pseudomonas aerogenosa 0 1 0 0 1 2 4 19 
Providencia rettigeri  0 0 1 2 0 3 6 14 
Staphylococcus  aureus 1 2 3 1 2 2 1 13 
Morgenella morganii 0 0 0 0 0 0 3 12 
Proteous vulgaris 1 0 2 0 2 1 3 1 
Proteous mirabilis 0 1 0 0 1 0 2 5 
Salmonella species  0 0 0 1 0 0 2 5 
Streptococcus species 1 1 0 1 0 0 0 1 
Serratia species 1 1 1 0 0 0 0 0 
Note: R0= No resistance, R1= Resistance to one antibiotic, R2= Resistance to two antibiotics,  
R3= Resistance to three antibiotics, R4= Resistance to four antibiotics,  
R5= Resistance to five antibiotics, R6= Resistance to six antibiotics,  
≥R7= Resistance to seven or more antibiotics 
 
Discussion  
In this study, of the total 3182 urine samples 742 
(23.32%) gave significant growth with ≥ 105 cfu/ml and 
no bacterial growth in 2440 (76.68%). The prevalence 
was lower here than some other studies: 60%, in Nigeria 
(21), 51.1%, in South Africa (22), and 30.2%, in Ethiopia 
(23).  The reason for this relatively lower rate of 
prevalence in this study might because of the fact that 
patients were undergoing through antibiotic treatment 
before coming to the hospital for diagnosis and the 
pathogens have been destroyed or inhibited. 
 
On the other hand, prevalence of UTIs showed slight 
increment from year: to year; 2008 (22.55%), 2009: 
(23.04%) and 2010 (24.18%) indicating UTI remains as 
an important public health problem at least in the study 
area. Calculated odds ratio of UTI in inpatients to 
outpatients shows likelihood of urinary tract infection in 
inpatients was 1.35 times higher than in outpatients. This 
finding coincides with other studies and demonstrated 
that the most were nosocomial and infections could have 
been acquired through unsafe health care practices such 
as catheterization (4-6).  
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Multiple infections were observed in 67 (9.03 %) of UTI 
patients and prevalence of UTI was higher in females 
428/1827 (23.43%) than males 314/1355 (23.17 %). 
These results also agree with other reports, which showed 
that UTIs are more common in females than in males 
(22-24).  This is because of their short urethra allowing 
quick access to bladder and the near source of bacteria 
from the vagina and anus. 
 
In this study age group classification was based on 
similar retrospective study done by Chadi et al. in 
Nigeria for comparison purposes. The highest age 
specific prevalence was found from age group of 21-30 
(27.16 %) years which strongly agreed with other studies 
signifying that sexually active groups, particularly 
females, are more prone to UTIs (23, 24). 
 
This study showed that gram-negative bacteria were 
more frequent (85.3%) than gram-positive bacteria 
(14.7%). Similar findings have been reported by Moges 
et al from Gondar Ethiopia and other studies done 
elsewhere (25-28). 
 
According to our study Escherichia coli was a 
predominant uropathogen and this also agreed with 
nearly all-similar researches (22-25).  This is due to the 
presence of a number of virulent factors specific for 
colonization and invasion of the urinary epithelium such 
as P-fimbria and S- fimbria adhesions (29). 
 
Despite, inconsistency and some inappropriateness in 
testing the drug susceptibility patterns, the results were 
summarized and analyzed accordingly. Because of their 
discontinued use the pathogens susceptibility patterns to 
Vancomycin, Cloxacilin, Streptomycin, Erythromycin 
and Mithicilin were not analyzed to avoid imprecision in 
interpretations. Bacterial uropathogen isolates from 
patients with UTIs revealed the presence of extremely 
high levels of single and multiple antimicrobial 
resistances to commonly prescribed drugs (Table 4).  
 
The gram-negative isolates were mainly sensitive to 
Ciprofloxacin (62.68%), Norfloxacin (61.08%) and 
Nitrofurantoin (50.49%) while they were commonly 
resistant to Amoxicillin (85.12 %), Ampicilin (81.22 %) 
and Tetracycline (80.02%). It was observed that gram-
positive isolates were relatively sensitive to 
Nitrofurantoin (66.30%), Chloramphinicol (60.55%) and 
Gentamycin (58.53%) while they were resistant to most 
antibiotics such as Ampicilin (81.7 %), Tetracycline 
(78.03 %) and Deoxicyclin (65.87 %). 
 
Generally, the in vitro sensitivity testing showed that 
both gram-negative and gram-positive organisms were 
extremely resistant to Ampcilin (83.93%), Amoxicillin 
(78.87%) and Tetracycline (77.75 %). This finding very 
much confers higher resistance rate than other studies 
(30, 31). This high level of resistance to beta lactam ring 
containing antibiotics (e.g., Ampcilin, Amoxicillin…) 
could happen because of the fact that the presence of 
extended spectrum β-Lactamase in these strains (32-34). 
Therefore, it is obvious that these antibiotics are no more 
useful against uropathogenes. 
 
The drug susceptibility pattern showed that isolated 
organisms were relatively sensitive to Nitrofurantoin 
(58.09%), and Ciprofloxacilin (57.4%). Hence, these 
drugs could be used as the drug of choice for treatment of 
uncomplicated UTIs. Comparatively, the lowest level of 
resistance was found against Nitrofurantoin might be due 
to its narrow range of clinical indications, which results 
in less usage (35). 
 
The highest level of resistance to common antibiotics 
was produced by Morganella morganii (76.75%), 
Klebsella spp (76.63%) and Pseudomonas aeurogenosa 
(72.81%) that demonstrated comparable finding with 
other studies (36). Complete resistance, was observed in 
Entrococcus spp and Pseudomonas aeurogenosa, to 
Penicillin: G, Morgenella morgenii; to Ampcilin: 
Tetracycline and Amoxicillin, and Salmonella spp; to 
Cefotaxim: The explanations could be a blaTEM10 that 
encodes extended spectrum Beta lactamase (ESBL) is 
already isolated from M. morganii where as the 
expression of a plasmid-mediated blaCMY-2 gene has 
been responsible for most Cefotaxim resistance in 
Salmonella spp (37, 38). 
 
According to this study, antibiotic susceptibility data 
revealed that, virtually all isolates 771 (95.3%) were 
resistant to at least one antibiotic and most of the isolates, 
747 (92.34%) were resistant against two or more 
antibiotics. These finding were extremely higher than a 
former done in Gondar study that showed 68% MDR, 
74% conducted in Tikur Anbessa Hospital (25, 39). 
These might be due to the increased rate of improper 
self-medication and an indiscriminate use of these 
antibiotics in Ethiopia that allowed organisms to acquire 
a plasmid encoded resistance gene (40). For these 
organisms, expensive broad spectrum antibiotics like 
Oxacillin, Carbapenems (Imipenem), Lovofloxacin, 
Amikacine, Fosfomycin Clindamycin, Erythromycine 
and Cephalosporin (Ceftrazidime) should be commenced 
as final treatment options for life threatening cases after 
the sensitivity report from microbiological laboratories. 
 
Limitations of theStudy  
• Incomplete information because of the lack of 
quality records. 
• Our findings may not be generalizable to specialized 




In conclusion, the prevalence of urinary tract infection 
was high, and gram-negative organisms were the most 
common causes of UTIs. Resistance was found to be 
extremely high to the commonly used antibiotics. It 
indicated that drug resistance is a deep-rooted problem in 
Ethiopia. 
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The development of drug resistance in uropathogens is 
usually, but not exclusively, the result of improper self-
medication. Antibiotic resistance can also be caused by 
inadequate treatment regimens, insufficient patient 
adherence, and uncontrolled distribution and trade of 
drugs, as well as lack and poor quality of antibiotics. For 
this reason it is to minimize the prevalence of urinary 
tract infections, and to monitor constantly susceptibility 
patterns of specific pathogens to commonly used 
antimicrobial agents. 
 
The most effective strategy to reduce antibiotic resistance 
is developing drug utilization management policies and 
procedures. Furthermore, there is a strong need for 
improving laboratory facilities and giving periodic 
additional training for laboratory technicians to upgrade 
their skill in identifying the responsible pathogenic 
organisms involved in urinary tract infections and to 
perform standardized drug susceptibility pattern tests. 
The hospital microbiology laboratory should produce and 
use standard result recording systems that may make it 
easy understand, analyze and interpret data.   Finally, a 
nationwide anti-microbial resistance survey and research 
is mandatory to assess this devastating situation across 
the country and develop controlling strategies. 
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